arsenic trisulfide has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, M; Wang, Z; Zhang, D | 1 |
1 other study(ies) available for arsenic trisulfide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Erythroblastic, Acute; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Spectrophotometry; Sulfides; Time Factors | 2007 |